Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001923614-23-000001
Filing Date
2023-04-12
Accepted
2023-04-12 15:01:13
Documents
1
Effectiveness Date
2023-04-12
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9065
  Complete submission text file 0001923614-23-000001.txt   10208
Mailing Address 100 PEARL STREET, 27TH FLOOR NEW YORK NY 10004
Business Address 100 PEARL STREET, 27TH FLOOR NEW YORK NY 10004 212-806-8800
Alger Life Sciences Innovation Fund LP (Filer) CIK: 0001923614 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-442344 | Film No.: 23815464